AMBRONAC TABLET is a combination of Ambroxol, and N-Acetylcysteine which belongs to the group of medicines called Mucolytics. It is used to manage or manage symptoms of chronic obstructive pulmonary diseases (COPD), such as coughing, shortness of breath or wheezing, tracheobronchitis (inflammation of airways (trachea and bronchi)), emphysema with bronchitis pneumoconiosis, and chronic inflammatory pulmonary conditions.
It also manages bronchiectasis (widening of airways of lungs), and bronchitis with bronchospasm asthma (tightening of the muscles of the bronchi causing shortness of breath), acute exacerbations of bronchitis and cystic fibrosis (an inherited disorder characterised by build-up of thick mucus in lungs).
AMBRONAC TABLET should be used with caution in patients with asthma, history of bronchospasm, bronchial motor activity disorder along with a large production of secretion, severe liver disease, moderate to severe kidney, high blood pressure, congestive heart failure, peptic ulcers, bleeding problems, undergoing any surgeries, epilepsy (convulsions).
AMBRONAC TABLET should be used in pregnancy only when it is clearly needed. Contact your doctor before taking it. AMBRONAC TABLET is not recommended for use in breastfeeding women as it may pass through the breast milk.
AMBRONAC TABLET is not recommended for use in children under the age of 6 years. The most common side effects of taking AMBRONAC TABLET are nausea, vomiting, stomach upset, diarrhea or constipation. Contact your doctor if symptoms do not improve.
No content available
